Initially used during the pandemic to study anonymised data for identifying new Covid-19 treatments, the platform – developed in collaboration with the University of Oxford – ensures that users do not access patient-identifiable information, and the data remains within the platform. OpenSAFELY’s success during the pandemic has prompted NHS England to seek support from GPs for its expansion into research beyond Covid-19.

Source: computing.co.uk